Talent Radar · Cybersecurity — India needs 250K+ security pros by 2028; supply covers about a third.

Get the report
The future of GCC hiring

GCC-as-a-service: what changes when the centre sells its capability outward

A handful of pharma centres now run charters for peers, not just the parent. That reshapes who they hire and what they pay for it.

By Sachith Rai 7 min read
Three professionals reviewing documents together

Draft. Figures marked like this are illustrative and pending verification against Recruise placement data & Sachith sign-off before publication.

Key takeaways

  1. A handful of pharma centres now run charters for peers, not just the parent — and that changes who they hire.
  2. Selling capability outward demands client-facing, commercially fluent leaders a captive centre never needed.
  3. GCC-as-a-service is a business-model shift wearing a talent-model shift underneath.
01

When the centre gets a second customer, the hire changes.

A captive pharma centre has exactly one customer: the parent. The moment it starts running charters for peer organisations — sharing a scarce capability outward rather than hoarding it — it acquires a second, and everything about the talent model shifts. Suddenly the centre needs people who can hold a client relationship, scope work that isn’t handed to them, and own a commercial outcome, not just a delivery one.

That’s a leader the captive model never had to hire. The regulatory-and-quality depth pharma always demanded is still non-negotiable — but now it has to sit alongside a commercial instinct the centre used to outsource entirely to the parent.

“The day a centre gets its second customer, the org chart looks the same and the hiring profile is unrecognisable. Client-facing and commercial stop being nice-to-haves.”

Sachith Rai · MD & Founder, Recruise

02

You’re now paying for judgment the parent used to supply.

Inside a captive, a lot of judgment lives upstream — the parent decides what’s worth doing and the centre executes cleanly. GCC-as-a-service repatriates that judgment. The centre has to price its own capability, decide which peers to serve, and stand behind outcomes for organisations that owe it no loyalty. That judgment isn’t free, and it doesn’t come from the existing bench.

So the comp conversation changes too. You’re no longer paying for delivery excellence at a captive discount; you’re paying for people who could run a services business, because that’s effectively what you’ve become. In pharma, where the trust bar is unforgiving, getting these hires right is what separates a service line from a liability.

The Signal · Weekly

One pattern worth knowing, every week.

The Signal is our weekly read on the senior GCC talent market — one chart, one pattern, no noise. Written from live placement data.